Bendamustine and Bevacizumab for Advanced Cancers

Clinical trial NCT01152203 · COMPLETED

Trial details

NCT number: NCT01152203
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2010-06-01
Primary completion: 2014-05-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.